Published in J Virol on October 03, 2007
Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention. Vet Res (2010) 3.78
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17
The pathogenesis of Rift Valley fever. Viruses (2011) 2.02
Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. J Virol (2008) 1.93
Gouleako virus isolated from West African mosquitoes constitutes a proposed novel genus in the family Bunyaviridae. J Virol (2011) 1.73
Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species. J Virol (2013) 1.33
Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses. Antiviral Res (2011) 1.24
Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann N Y Acad Sci (2009) 1.24
Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol (2009) 1.24
Rift valley fever: recent insights into pathogenesis and prevention. J Virol (2011) 1.21
Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res (2012) 1.21
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis (2012) 1.18
Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus. J Virol (2012) 1.17
Discovery of a unique novel clade of mosquito-associated bunyaviruses. J Virol (2013) 1.17
Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res (2009) 1.16
Creation of a nonspreading Rift Valley fever virus. J Virol (2011) 1.16
Creation of a recombinant Rift Valley fever virus with a two-segmented genome. J Virol (2011) 1.08
Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNA. PLoS One (2010) 1.05
p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production. PLoS One (2012) 1.03
Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem (2010) 1.02
Evolutionary and phenotypic analysis of live virus isolates suggests arthropod origin of a pathogenic RNA virus family. Proc Natl Acad Sci U S A (2015) 1.01
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep. Vaccine (2012) 0.99
Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells. PLoS One (2010) 0.98
Molecular biology of rift valley Fever virus. Open Virol J (2010) 0.98
Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge. J Virol (2012) 0.97
The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function. J Virol (2012) 0.96
Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice. PLoS One (2011) 0.95
Emerging phleboviruses. Curr Opin Virol (2014) 0.94
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. PLoS Negl Trop Dis (2010) 0.94
Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains. J Virol (2012) 0.92
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves. Vaccine (2013) 0.92
Phleboviruses and the Type I Interferon Response. Viruses (2016) 0.90
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. J Virol (2015) 0.89
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes. PLoS Negl Trop Dis (2014) 0.89
Curcumin inhibits Rift Valley fever virus replication in human cells. J Biol Chem (2012) 0.89
Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One (2011) 0.89
A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. Vector Borne Zoonotic Dis (2014) 0.87
Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. Vector Borne Zoonotic Dis (2013) 0.87
Advances in Rift Valley fever research: insights for disease prevention. Curr Opin Infect Dis (2010) 0.87
The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts. Emerg Microbes Infect (2014) 0.87
Non-structural proteins of arthropod-borne bunyaviruses: roles and functions. Viruses (2013) 0.85
Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection. J Virol (2012) 0.85
Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model. PLoS Negl Trop Dis (2014) 0.85
Creation of Rift Valley fever viruses with four-segmented genomes reveals flexibility in bunyavirus genome packaging. J Virol (2014) 0.85
A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs. PLoS One (2013) 0.85
Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses. J Virol (2013) 0.84
The Rift Valley Fever virus protein NSm and putative cellular protein interactions. Virol J (2012) 0.83
Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOP mRNAs restricts viral infection. Proc Natl Acad Sci U S A (2015) 0.83
Interplay between the Virus and Host in Rift Valley Fever Pathogenesis. J Innate Immun (2015) 0.81
Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs. Future Virol (2014) 0.79
Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease. Virol J (2015) 0.79
Identification of super-infected Aedes triseriatus mosquitoes collected as eggs from the field and partial characterization of the infecting La Crosse viruses. Virol J (2010) 0.79
NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR. J Virol (2016) 0.78
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype. J Virol (2016) 0.78
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins. Virol J (2016) 0.78
Development of a novel, single-cycle replicable rift valley Fever vaccine. PLoS Negl Trop Dis (2014) 0.77
The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release. Viruses (2016) 0.77
Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis. Expert Rev Mol Med (2016) 0.76
Transstadial Transmission and Long-term Association of Crimean-Congo Hemorrhagic Fever Virus in Ticks Shapes Genome Plasticity. Sci Rep (2016) 0.75
Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence. PLoS Negl Trop Dis (2016) 0.75
N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN. Viruses (2016) 0.75
Single-Molecule FISH Reveals Non-selective Packaging of Rift Valley Fever Virus Genome Segments. PLoS Pathog (2016) 0.75
Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells. Front Microbiol (2016) 0.75
Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene. J Virol (2013) 0.75
Vector competence of Aedes vexans (Meigen), Culex poicilipes (Theobald) and Cx. quinquefasciatus Say from Senegal for West and East African lineages of Rift Valley fever virus. Parasit Vectors (2016) 0.75
Akabane virus nonstructural protein NSm regulates viral growth and pathogenicity in a mouse model. J Vet Med Sci (2016) 0.75
Current Status of Rift Valley Fever Vaccine Development. Vaccines (Basel) (2017) 0.75
Sorafenib impedes Rift Valley fever virus egress by inhibiting Valosin-containing protein function in the cellular secretory pathway. J Virol (2017) 0.75
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. Vaccine (2017) 0.75
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 16.08
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods (1995) 16.00
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 13.87
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med (1995) 10.91
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science (1985) 7.99
Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem (1985) 6.28
Viruses and apoptosis. Annu Rev Microbiol (1999) 4.24
Caspase function in programmed cell death. Cell Death Differ (2006) 3.77
NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol (2004) 3.52
TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell (2004) 3.39
Viruses and apoptosis. Curr Opin Genet Dev (1995) 3.26
Rift Valley fever: an uninvited zoonosis in the Arabian peninsula. Int J Antimicrob Agents (2003) 2.96
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci U S A (2001) 2.80
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Rift Valley fever outbreak--Kenya, November 2006-January 2007. MMWR Morb Mortal Wkly Rep (2007) 2.63
Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J (1998) 2.56
Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. J Virol (2007) 2.44
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A (2006) 2.31
Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol (2003) 2.19
Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus. J Virol (2001) 1.92
The fight of viruses against apoptosis. Curr Opin Genet Dev (1998) 1.88
The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. Virology (2006) 1.86
Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. Virology (2007) 1.86
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol (2006) 1.81
Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol (2005) 1.72
Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. J Virol (2005) 1.68
Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J Virol (2003) 1.67
Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins. Virology (2006) 1.61
Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein. J Virol (2002) 1.59
Rift Valley fever virus M segment: phlebovirus expression strategy and protein glycosylation. Virology (1989) 1.53
Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment. J Virol (1990) 1.50
Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J Virol (2006) 1.46
Caspase inhibitors: viral, cellular and chemical. Cell Death Differ (2006) 1.45
Vector potential of selected North American mosquito species for Rift Valley fever virus. Am J Trop Med Hyg (1988) 1.40
Picornaviruses and cell death. Trends Microbiol (2005) 1.38
Staurosporine-induced apoptosis of cultured rat hippocampal neurons involves caspase-1-like proteases as upstream initiators and increased production of superoxide as a main downstream effector. J Neurosci (1998) 1.32
Inhibition of translation and induction of apoptosis by Bunyaviral nonstructural proteins bearing sequence similarity to reaper. Mol Biol Cell (2003) 1.32
Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene (2001) 1.29
Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells. J Virol (2002) 1.27
Rift Valley fever virus M segment: use of recombinant vaccinia viruses to study Phlebovirus gene expression. J Virol (1988) 1.26
Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol (2006) 1.19
Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ (2006) 1.07
Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol (2004) 0.99
Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA. Virology (1988) 0.95
The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C. Cell Death Differ (2000) 0.87
Physiological significance of apoptosis during animal virus infection. Int Rev Immunol (2003) 0.85
Recruitment of TRADD, FADD, and caspase 8 to double-stranded RNA-triggered death inducing signaling complexes (dsRNA-DISCs). Apoptosis (2005) 0.84
Apoptosis of hepatocytes caused by Punta Toro virus (Bunyaviridae: Phlebovirus) and its implication for Phlebovirus pathogenesis. Am J Pathol (2005) 0.80
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Gene expression analysis of zebrafish heart regeneration. PLoS Biol (2006) 3.00
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Nongenetic method for purifying stem cell-derived cardiomyocytes. Nat Methods (2009) 2.64
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
fgf20 is essential for initiating zebrafish fin regeneration. Science (2005) 2.43
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation. Proc Natl Acad Sci U S A (2006) 2.31
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis (1997) 2.19
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17
Sema3a maintains normal heart rhythm through sympathetic innervation patterning. Nat Med (2007) 2.16
Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg (1998) 2.11
The phylogeny of New World (Tacaribe complex) arenaviruses. Virology (1996) 2.11
Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis (2001) 2.07
Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun (2008) 2.04
Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
The pathogenesis of Rift Valley fever. Viruses (2011) 2.02
Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology (1994) 2.01
Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.99
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol (1999) 1.92
General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol (1989) 1.91
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol (2005) 1.90
Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg Infect Dis (2000) 1.88
Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology (1996) 1.87
Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. J Virol (1998) 1.87
A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg (1992) 1.86
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol (2006) 1.81
The incubation period of hantavirus pulmonary syndrome. Am J Trop Med Hyg (2000) 1.81
Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation (2006) 1.76
A newly recognized virus associated with a fatal case of hantavirus pulmonary syndrome in Louisiana. J Virol (1995) 1.76
Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine (1996) 1.74
Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis (1999) 1.74
Spectrum of Rift Valley fever virus transmission in Kenya: insights from three distinct regions. Am J Trop Med Hyg (2007) 1.73
Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment. J Virol (2005) 1.72
Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med (1992) 1.71
Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. Am J Trop Med Hyg (1991) 1.70
Search for the Ebola virus reservoir in Kikwit, Democratic Republic of the Congo: reflections on a vertebrate collection. J Infect Dis (1999) 1.70
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J Virol (2008) 1.69
Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis (1998) 1.69
An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg (1997) 1.68
Naturally occurring Sin Nombre virus genetic reassortants. Virology (1995) 1.67
Recombinant human monoclonal antibodies to Ebola virus. J Infect Dis (1999) 1.65
Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol (2005) 1.64
Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol (2000) 1.63
An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg (1997) 1.62
Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med (1997) 1.60
Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic. Arch Virol Suppl (1996) 1.58
Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon. Emerg Infect Dis (1997) 1.56
Neurovirulent Toscana virus (a sandfly fever virus) in Swedish man after visit to Portugal. Lancet (1985) 1.55
Hantavirus transmission in the United States. Emerg Infect Dis (1997) 1.55